A multicenter, open label, phase 3 study of tabelecleucel for solid organ transplant subjects with Epstein-Barr virus-driven post-transplant lymphoproliferative disease (EBV+PTLD) after failure of rituximab or rituximab and chemotherapy Meeting Abstract
| Authors: | Prockop, S.; Hiremath, M.; Ye, W.; Gamelin, L.; Navarro, W.; Mahadeo, K. M. |
| Abstract Title: | A multicenter, open label, phase 3 study of tabelecleucel for solid organ transplant subjects with Epstein-Barr virus-driven post-transplant lymphoproliferative disease (EBV+PTLD) after failure of rituximab or rituximab and chemotherapy |
| Meeting Title: | 61st Annual Meeting and Exposition of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 134 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2019 Dec 7-10 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2019-11-13 |
| Language: | English |
| ACCESSION: | WOS:000577164606045 |
| DOI: | 10.1182/blood-2019-129277 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 5326 -- Source: Wos |
